Pfizer Inc. and NovaMedica have completed the last stage of negotiations

Print 29 December 2016
BM - Breaking News and Headlines

Pfizer Inc. (NYSE:PFE) and Russia’s NovaMedica, a company established in 2012 by Russian high-technology investment fund Rusnano and American healthcare fund Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio.

Pfizer Inc. (NYSE:PFE) traded 13.68 Million shares and was closed at $32.35 per share. The current share price indicates that stock is -11.89% away from its one year high and is moving 17.66% ahead of its one year low. Stock monthly performance is recorded as 2.57% while its performance in last 5 sessions is -1.52%.

Analyst’s Analysis on Pfizer Inc. (NYSE:PFE)

At the movement stock is under coverage by number of analysts. 4 given Buy rating to the stock whereas no analyst given UNDERPERFORM rating to stock and 11 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 2.32 on scale of 1-5. Analysts mean target price for Pfizer Inc. (NYSE:PFE) is $37.65 while their mean recommendation is 2.50 (1=Buy, 5=sell).

Memorial Production Partners LP (NASDAQ:MEMP) entered into plan support deal with holders of 50.2% of partnership’s 7.625% senior notes due 2021.

Memorial Production Partners LP (NASDAQ:MEMP) shares moved to $0.16 on Wednesday. Weekly volatility of MEMP is 33.92% and monthly volatility is 25.15%. Stock performance in last five sessions is recorded as -65.43% while year to date (YTD) performance is -93.53%. MEMP Gross Margin is 52.50% and its return on assets is -5.40%. Stock 3 months performance is recorded as -89.94%.

Analyst Rating on Memorial Production Partners LP (NASDAQ:MEMP)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from no analyst of Thomson Reuters, 3 analysts given HOLD rating to the stock and 2 given UNDERPERFORM rating. Analyst’s mean target price for MEMP is $22.00 while analysts mean recommendation is 3.50.

American Express Company (NYSE:AXP) traded 2.49 Million shares and was closed at $74.37 per share. The current share price indicate that stock is -1.81% away from its one year high and is moving 50.16% ahead of its one year low. Stock monthly performance is recorded as 3.11% while its performance in last 5 sessions is -0.92%.

Analyst’s Analysis on American Express Company (NYSE:AXP)

At the movement stock is under coverage by number of analysts. At the movement stock is under coverage by number of analysts. 5 given Buy rating to the stock whereas 4 analysts given UNDERPERFORM rating to stock and 19 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Hold and their mean rating for the stock is 2.78 on scale of 1-5. Analysts mean target price for American Express Company (NYSE:AXP) is $72.88 while their mean recommendation is 2.80 (1=Buy, 5=sell).

Parsley Energy, Inc. (NYSE:PE) shares moved to $35.66 after starting the day at $35.94 on Wednesday. Weekly volatility of PE is 1.90% and monthly volatility is 3.80%. Stock performance in last five sessions is recorded as -0.47% while year to date (YTD) performance is 93.28%. PE Gross Margin is 78.20% and its return on assets is -2.00%. Firm quarterly performance is 8.85%.

Analyst Recommendation on Parsley Energy, Inc. (NYSE:PE)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 17 analysts of Thomson Reuters, 4 analysts given HOLD rating to the stock and 0 given UNDERPERFORM rating to Parsley Energy, Inc. (NYSE:PE) stock. Analyst’s mean target price for PE is $43.52 while analysts mean recommendation is 1.80.

Source

Return